Evidence map›Paper›PMID 34606421›Full record

ArticleBioengineered2021

β-galactosidase GALA from

Yaru Yan, Weishi Guan, Xiaoyi Li, Kaier Gao, Xinxin Xu, Bo Liu, Wei Zhang, Yuhong Zhang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yaru YanBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Weishi GuanBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Xiaoyi LiCollege of Letters and Science, University of California, Santa Barbara, Santa Barbara, California, USA.
Kaier GaoBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Xinxin XuBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Bo LiuBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Wei ZhangBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Yuhong ZhangBiotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China.
Chinese Academy of Agricultural Sciences · CNBiotechnology Research Institute · CNUniversity of California, Santa Barbara · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-galactosidase catalyzes lactose hydrolysis and transfers reactions to produce prebiotics such as galacto-oligosaccharides (GOS) with potential applications in the food industry and pharmaceuticals. However, there is still a need for improved transgalactosylation activity of β-galactosidases and reaction conditions of GOS production in order to maximize GOS output and reduce production costs. In this study, a β-galactosidase gene,

Indexed as

BacillusBacterial Proteinsbeta-GalactosidaseGalactoseHydrogen-Ion ConcentrationKineticsTemperatureBacterial Proteinsbeta-GalactosidaseGalactoseBacillus circulansGalacto-oligosaccharidesPichia pastorisresponse surface methodologytransgalactosylationβ-Galactosidase

Identifiers

PMID34606421
PMCPMC8806947
OpenAlexW3203809963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.